Tuesday, January 17, 2017

Tag: VRX

Worth Watching Stock: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Investors Catching Stocks: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Research Report for: Valeant Pharmaceuticals International, Incorporated (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Price Target Analysis: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Analysts showing optimistic trends for: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Comprehensive Stock Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

What are Analysts opinions on: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Recent analysts Ratings: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

What do Analysts suggest for: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Revenue Estimates Analysis: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

Earnings Analysis of: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...

What are analysts Suggestions on: Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) reported the earnings of $1.55/Share in the last quarter where the estimated EPS by analysts was $1.75/share. The difference...